1. Home
  2. BHST vs LUCD Comparison

BHST vs LUCD Comparison

Compare BHST & LUCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BHST
  • LUCD
  • Stock Information
  • Founded
  • BHST 2007
  • LUCD 2018
  • Country
  • BHST Canada
  • LUCD United States
  • Employees
  • BHST N/A
  • LUCD N/A
  • Industry
  • BHST
  • LUCD Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • BHST
  • LUCD Health Care
  • Exchange
  • BHST Nasdaq
  • LUCD Nasdaq
  • Market Cap
  • BHST 106.0M
  • LUCD 119.7M
  • IPO Year
  • BHST N/A
  • LUCD 2021
  • Fundamental
  • Price
  • BHST $6.46
  • LUCD $1.49
  • Analyst Decision
  • BHST Strong Buy
  • LUCD Strong Buy
  • Analyst Count
  • BHST 2
  • LUCD 4
  • Target Price
  • BHST $13.00
  • LUCD $3.75
  • AVG Volume (30 Days)
  • BHST 11.2K
  • LUCD 899.8K
  • Earning Date
  • BHST 03-31-2025
  • LUCD 03-24-2025
  • Dividend Yield
  • BHST N/A
  • LUCD N/A
  • EPS Growth
  • BHST N/A
  • LUCD N/A
  • EPS
  • BHST N/A
  • LUCD N/A
  • Revenue
  • BHST $22,430,000.00
  • LUCD $4,346,000.00
  • Revenue This Year
  • BHST $161.11
  • LUCD $156.40
  • Revenue Next Year
  • BHST $64.74
  • LUCD $206.37
  • P/E Ratio
  • BHST N/A
  • LUCD N/A
  • Revenue Growth
  • BHST 111.68
  • LUCD 79.00
  • 52 Week Low
  • BHST $0.00
  • LUCD $0.63
  • 52 Week High
  • BHST $7.38
  • LUCD $1.63
  • Technical
  • Relative Strength Index (RSI)
  • BHST N/A
  • LUCD 54.96
  • Support Level
  • BHST N/A
  • LUCD $1.43
  • Resistance Level
  • BHST N/A
  • LUCD $1.60
  • Average True Range (ATR)
  • BHST 0.00
  • LUCD 0.12
  • MACD
  • BHST 0.00
  • LUCD 0.00
  • Stochastic Oscillator
  • BHST 0.00
  • LUCD 72.50

About BHST BioHarvest Sciences Inc. Common Stock

BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.

About LUCD Lucid Diagnostics Inc.

Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.

Share on Social Networks: